Clinical Trial Update: Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis

View source ↗

Summary

This document outlines a real-world study comparing the effectiveness and safety of combining upadacitinib with vedolizumab versus upadacitinib alone for induct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Upadacitinib (Rinvoq) (upadacitinib)
• Vedolizumab (Entyvio) (Vedolizumab)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Ulcerative Colitis (UC) | Status: RECRUITING